| NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD) (NCT05189925) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-07-22 |
| Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists (NCT05463133) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-07-08 |
| Elemental Diet for Treatment of Inflammatory Bowel Disease in Patients With Chronic Granulomatous Disease (NCT03983837) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-06-23 |
| Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide (NCT03910452) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-10-28 |
| Vitamin D3 For CGD Patients With BCGosis/Itis (NCT03984890) | Children's Hospital of Fudan University | 2019-08-01 |
| Plerixafor/G-CSF as Additional Agents for Conditioning Before HSCT in CGD Patients (NCT03547830) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2019-04-13 |
| Early Check: Expanded Screening in Newborns (NCT03655223) | RTI International | 2018-10-15 |
| Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation (NCT03513328) | University of Florida | 2018-06-15 |
| Role of Interferon-gamma 1-b (IFN-γ) on Cells of the Innate Immune System: Functional, Biochemical and Gene Expression Studies in Patients With Chronic Granulomatous Disease (NCT03548818) | University of Colorado, Denver | 2018-05-16 |
| Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer (NCT03333486) | Roswell Park Cancer Institute | 2017-12-07 |
| Pioglitazone Therapy for Chronic Granulomatous Disease (NCT03080480) | Children's Hospital of Fudan University | 2017-09-01 |
| Effect of IFN-γ on Innate Immune Cells (NCT02609932) | University of Colorado, Denver | 2016-07-01 |
| IL-1 Receptor Inhibitor for Granulomatous Complications in Patients With Chronic Granulomatous Disease (NCT04136028) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2015-09-25 |
| Haploidentical Transplant for People With Chronic Granulomatous Disease Using Post Transplant Cyclophosphamide (NCT02282904) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-10-23 |
| Analysis of Patients Treated for Chronic Granulomatous Disease Since January 1, 1995 (NCT02116764) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-06-11 |
| Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer (NCT02108028) | National Cancer Institute (NCI) | 2014-04-03 |
| Bone Marrow Transplant With Abatacept for Non-Malignant Diseases (NCT01917708) | Emory University | 2014-01-01 |
| Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204) (NCT01998633) | Medical College of Wisconsin | 2013-12-01 |
| Immune Disorder HSCT Protocol (NCT01821781) | Washington University School of Medicine | 2013-04-29 |
| Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies (NCT01652092) | Masonic Cancer Center, University of Minnesota | 2012-09-04 |
| Targeted Busulfan, Fludarabine Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Chronic Granulomatous Disease(CGD) (NCT01338675) | Seoul National University Hospital | 2011-01-01 |
| Generation of Powerful Biological Tools for Understanding the Pathophysiology of Chronic Granulomatous Disease. (NCT02926963) | University Hospital, Grenoble | 2010-10-01 |
| Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation (NCT01319851) | Emory University | 2010-09-01 |
| Pharmacokinetics of Posaconazole in Children With Chronic Granulomatous Disease (CGD) (NCT00799071) | Radboud University Medical Center | 2009-02-01 |
| Related Hematopoietic Stem Cell Transplantation (HSCT) for Genetic Diseases of Blood Cells (NCT02512679) | Children's Hospital Los Angeles | 2007-02-01 |
| Gene Therapy for Chronic Granulomatous Disease (NCT00394316) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-10-30 |
| Genetic Disorders of Mucociliary Clearance in Nontuberculous Mycobacterial Lung Disease (NCT00368446) | National Heart, Lung, and Blood Institute (NHLBI) | 2006-10-17 |
| Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease (NCT00325078) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-05-01 |
| Gene Therapy for X-linked Chronic Granulomatous Disease (CGD) in Children (NCT00927134) | University of Zurich | 2004-06-01 |
| Matched Unrelated or Non-Genotype Identical Related Donor Transplantation For Chronic Granulomatous Disease (NCT00578643) | Baylor College of Medicine | 2004-03-01 |
| Modified Stem Cell Transplantation Procedure for Treating Chronic Granulomatous Disease (NCT00006417) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-10-01 |
| Learning and Behavior Problems in Children With Chronic Granulomatous Disease and Related Disorders (NCT00005933) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-06-01 |
| Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies (NCT00006054) | Fairview University Medical Center | 2000-03-01 |
| Stem Cell Transplant Following Low-Intensity Chemotherapy to Treat Chronic Granulomatous Disease (NCT00001765) | National Institute of Allergy and Infectious Diseases (NIAID) | 1998-04-01 |
| Diagnostic Effectiveness of Virtual Bronchoscopy (NCT00001515) | National Institutes of Health Clinical Center (CC) | 1995-12-01 |
| Gene Therapy for Chronic Granulomatous Diseases - Long-term Follow-up (NCT00001476) | National Institute of Allergy and Infectious Diseases (NIAID) | 1995-06-01 |
| A Phase IV Study of Recombinant Human Gamma Interferon in Patients With Chronic Granulomatous Diseases of Childhood (NCT00001317) | National Institute of Allergy and Infectious Diseases (NIAID) | 1992-05-01 |